WuXi Biologics Recognized by FTSE4Good for the Sixth Consecutive Year, Underscoring Value Creation Through Green CRDMO

Positive

AI Analysis

Summary

WuXi Biologics has been included in the FTSE4Good Index Series for the sixth consecutive year, recognizing its sustainability performance and value creation through green CRDMO services.

Importance:3/10

Sentiment:

0.60

sustainabilityESGFTSE4GoodCRDMOcorporate recognition

Related Companies

$2269.HK

Read the original article

Published by PR Newswire Biotech on July 29, 2026 2:27 AM

Read Original